Biotech

Immunai, Bristol Myers Squibb sign AI immune-data collaboration

The New York-based AI biotech will use its AMICA-OS platform to analyze clinical immune data for BMS, aiming to inform patient stratification, biomarkers, and trial decisions.

 CEO and co-founder of Immunai Noam Solomon.
WORKERS TAKE care of cannabis plants at a farm in central Israel,  late last year.

Israeli researchers develop SafeWax coating that could cut pesticide use by 50%

 Heart hologram and doctor, heart disease. Health care of the future. Modern Medical Science, Hi Tech Diagnostic Panel. Mixed medium, copy space

Arkin raises $100m for early-stage biotech fund

Automated pharmaceutical conveyor line, robotic arms handling medical vials

Israel's biotech moment: How science, data, and geopolitics are converging - opinion


Precise Bio partners with ZEISS to develop bio-printed cornea implants

These bio-printed eye tissues would be used for transplants to treat vision correction and corneal diseases such as keratoconus.

 Precise Bio's bio-fabricated cornea

BioGenCell raises $16m. for chronic disease treatment

The company’s treatment has already prevented loss of limb in several patients during Phase I trials.

 Microglia (green) that were “matured” in the lab from stem cells of ALS patients; the cells’ nuclei are in blue. Viewed with confocal microscopy

AI bio-tech company Nucleai raises $33M, brings in new executives

Nuclei aims to use the funds to further its efforts to transform drug development and clinical treatments.

 Nucleai's team

Israeli Biotech company says it can revolutionize drug development

Tissue Dynamics Ltd., an Israeli biotechnology company, says it can cut drug development cost by 40% to 80% and the time required by 30% to 50%.

 Best Weight Loss Pills

‘Cell-based, innovative products for a better future’

Pluristem’s proprietary cell-based technology platform develops cutting-edge therapies and cultured food materials

 IN COLLABORATION with the Tnuva Group, Pluristem will develop raw material for the cultured meat market.

Reimagining the future of food

Israel’s northern Galilee has become the new go-to destination for food-tech start-ups

 Planteam’s plant protein made without fillers, binders, mediators, gluten, additives, preservatives, or GMO

3D bioprinting tech to be licensed by Tel Aviv University

The technology was used to print a heart made of human cells and extracellular matrix at TAU in 2019.

A 3D printed, small-scaled human heart engineered from the patient’s own materials and cells.

New method for mapping gene expression could be used alongside cancer therapy - study

Findings by Israeli scientists may completely change the way we approach observing the biological processes of the human body in the future.  

 Bar-Shir team - Dr. Amnon Bar-Shir and Dr. Hyla Allouche-Arnon

Israeli biotech company paves a new way in healing injured spinal cords

The company successfully used human implants for replacing the injured spinal cord of a living pig, thereby simulating the anticipated surgical procedure in humans.

 Piglets at a pig farm.